{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:02:43Z","timestamp":1790204563652,"version":"4.1.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,5]]},"DOI":"10.18632\/oncotarget.7761","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T04:08:49Z","timestamp":1456546129000},"page":"18325-18345","source":"Crossref","is-referenced-by-count":34,"title":["Class II phosphoinositide 3-kinase C2\u03b2 regulates a novel signaling pathway involved in breast cancer progression"],"prefix":"10.18632","volume":"7","author":[{"given":"Anissa","family":"Chikh","sequence":"first","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Ferro","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Abbott","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Buus","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Iezzi","sequence":"additional","affiliation":[{"name":"Aging Research Centre (Ce.S.I.), Foundation University \u201cG. d'Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ricci","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology IRCCS-Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bergamaschi","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ostano","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Fondazione Edo and Elvo Tempia, Biella, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Chiorino","sequence":"additional","affiliation":[{"name":"Cancer Genomics Laboratory, Fondazione Edo and Elvo Tempia, Biella, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossano","family":"Lattanzio","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, University \u201cG. d'Annunzio\u201d, Chieti, Italy"},{"name":"Aging Research Centre (Ce.S.I.), Foundation University \u201cG. d'Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Broggini","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology IRCCS-Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Piantelli","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, University \u201cG. d'Annunzio\u201d, Chieti, Italy"},{"name":"Aging Research Centre (Ce.S.I.), Foundation University \u201cG. d'Annunzio\u201d, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Maffucci","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falasca","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK"},{"name":"Metabolic Signalling Group, School of Biomedical Sciences, CHIRI Biosciences, Curtin University, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1172\/JCI57152","article-title":"Targeted therapies for breast cancer","volume":"121","author":"Baselga","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"2","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Cantley","year":"2008","journal-title":"Oncogene"},{"key":"3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","article-title":"Targeting the PI3K signaling pathway in cancer","volume":"20","author":"Cantley","year":"2010","journal-title":"Current opinion in genetics & development"},{"key":"4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2174\/138161210791033950","article-title":"PI3K\/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs","volume":"16","author":"Falasca","year":"2010","journal-title":"Current pharmaceutical design"},{"key":"5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Bilanges","year":"2010","journal-title":"Nature reviews Molecular cell biology"},{"key":"6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/bcr3039","article-title":"Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer","volume":"13","author":"Arteaga","year":"2011","journal-title":"Breast cancer research"},{"key":"7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/BJ20120008","article-title":"Regulation and cellular functions of class II phosphoinositide 3-kinases","volume":"443","author":"Maffucci","year":"2012","journal-title":"The Biochemical journal"},{"key":"8","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1158\/1078-0432.CCR-04-2165","article-title":"Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation","volume":"11","author":"Ritz","year":"2005","journal-title":"Clinical cancer research"},{"key":"9","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.222491799","article-title":"Expression profiling of CD34+ hematopoietic stem\/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia","volume":"99","author":"Le Beau","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1750-3639.2003.tb00481.x","article-title":"Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3\u2032-kinase\/protein kinase B (Akt) signal transduction pathway in glioblastomas","volume":"13","author":"Reifenberger","year":"2003","journal-title":"Brain pathology"},{"key":"11","first-page":"3015","article-title":"Targeting PI3KC2beta impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours","volume":"32","author":"Schweri-Olac","year":"2012","journal-title":"Anticancer research"},{"key":"12","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1093\/emboj\/cdf512","article-title":"Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation","volume":"21","author":"Seckl","year":"2002","journal-title":"The EMBO journal"},{"key":"13","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1038\/onc.2011.643","article-title":"Intersectin 1 is required for neuroblastoma tumorigenesis","volume":"31","author":"O'Bryan","year":"2012","journal-title":"Oncogene"},{"key":"14","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1158\/0008-5472.CAN-09-3575","article-title":"Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer","volume":"70","author":"Kaaks","year":"2010","journal-title":"Cancer research"},{"key":"15","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/carcin\/bgs148","article-title":"Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing","volume":"33","author":"Tschannen","year":"2012","journal-title":"Carcinogenesis"},{"key":"16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200408005","article-title":"Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration","volume":"169","author":"Falasca","year":"2005","journal-title":"The Journal of cell biology"},{"key":"17","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1091\/mbc.e05-11-1083","article-title":"Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms","volume":"17","author":"Arcaro","year":"2006","journal-title":"Molecular biology of the cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.canlet.2015.01.026","article-title":"Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2beta) isoform contributes to neuroblastoma tumorigenesis","volume":"359","author":"O'Bryan","year":"2015","journal-title":"Cancer letters"},{"key":"19","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/MCB.20.11.3817-3830.2000","article-title":"Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors","volume":"20","author":"Domin","year":"2000","journal-title":"Molecular and cellular biology"},{"key":"20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1261\/rna.1963810","article-title":"Role of miR-34c microRNA in the late steps of spermatogenesis","volume":"16","author":"Rouault","year":"2010","journal-title":"Rna"},{"key":"21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ncb2241","article-title":"Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta\/Notch pathway","volume":"13","author":"Barbry","year":"2011","journal-title":"Nature cell biology"},{"key":"22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000101303","article-title":"Beta-catenin\/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs","volume":"185","author":"Grunert","year":"2007","journal-title":"Cells, tissues, organs"},{"key":"23","first-page":"2714","article-title":"The many faces and functions of beta-catenin","volume":"31","author":"Basler","year":"2012","journal-title":"The EMBO journal"},{"key":"24","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1158\/0008-5472.CAN-12-3925","article-title":"beta-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression","volume":"73","author":"Muller","year":"2013","journal-title":"Cancer research"},{"key":"25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.18632\/oncotarget.167","article-title":"miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells","volume":"1","author":"Li","year":"2010","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-10-29","article-title":"miR-449 inhibits cell proliferation and is down-regulated in gastric cancer","volume":"10","author":"Friis-Hansen","year":"2011","journal-title":"Molecular cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1158\/0008-5472.CAN-10-0226","article-title":"WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration","volume":"70","author":"McDonnell","year":"2010","journal-title":"Cancer research"},{"key":"28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/0008-5472.CAN-13-2319","article-title":"The structural basis of PI3K cancer mutations: from mechanism to therapy","volume":"74","author":"Ahmed","year":"2014","journal-title":"Cancer research"},{"key":"29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BST0350211","article-title":"Role of class II phosphoinositide 3-kinase in cell signalling","volume":"35","author":"Maffucci","year":"2007","journal-title":"Biochemical Society transactions"},{"key":"30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1042\/BST20140140","article-title":"New insight into the intracellular roles of class II phosphoinositide 3-kinases","volume":"42","author":"Falasca","year":"2014","journal-title":"Biochemical Society transactions"},{"key":"31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Schultz","year":"2012","journal-title":"Cancer discovery"},{"key":"32","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Schultz","year":"2013","journal-title":"Science signaling"},{"key":"33","first-page":"15","article-title":"Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses","volume":"150","author":"Uchikoshi","year":"1997","journal-title":"The American journal of pathology"},{"key":"34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1388-1981(02)00356-6","article-title":"Nuclear phosphoinositide 3-kinase C2beta activation during G2\/M phase of the cell cycle in HL-60 cells","volume":"1631","author":"Banfic","year":"2003","journal-title":"Biochimica et biophysica acta"},{"key":"35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/0008-5472.CAN-03-3321","article-title":"Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis","volume":"64","author":"Gong","year":"2004","journal-title":"Cancer research"},{"key":"36","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1158\/1078-0432.CCR-08-3293","article-title":"Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer","volume":"15","author":"Gray","year":"2009","journal-title":"Clinical cancer research"},{"key":"37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.25091","article-title":"Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort","volume":"127","author":"Fjallskog","year":"2010","journal-title":"International journal of cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","article-title":"miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors","volume":"6","author":"Yakhini","year":"2011","journal-title":"PloS one"},{"key":"39","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1101\/gad.1819009","article-title":"miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A","volume":"23","author":"Yu","year":"2009","journal-title":"Genes & development"},{"key":"40","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations","volume":"47","author":"Zucman-Rossi","year":"2008","journal-title":"Hepatology"},{"key":"41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1476-4598-9-252","article-title":"MicroRNA roles in beta-catenin pathway","volume":"9","author":"Kang","year":"2010","journal-title":"Molecular cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/onc.2011.86","article-title":"beta-Catenin is required for Ron receptor-induced mammary tumorigenesis","volume":"30","author":"Waltz","year":"2011","journal-title":"Oncogene"},{"key":"43","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.060025397","article-title":"Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression","volume":"97","author":"Hung","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"44","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI73531","article-title":"IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis","volume":"124","author":"Hermeking","year":"2014","journal-title":"The Journal of clinical investigation"},{"key":"45","doi-asserted-by":"crossref","first-page":"e64759","DOI":"10.1371\/journal.pone.0064759","article-title":"MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met","volume":"8","author":"Wang","year":"2013","journal-title":"PloS one"},{"key":"46","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1158\/0008-5472.CAN-08-1181","article-title":"Phospholipase Cgamma1 is required for metastasis development and progression","volume":"68","author":"Falasca","year":"2008","journal-title":"Cancer research"},{"key":"47","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1242\/jcs.100511","article-title":"A novel regulatory mechanism links PLCgamma1 to PDK1","volume":"125","author":"Falasca","year":"2012","journal-title":"Journal of cell science"},{"key":"48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ijc.27751","article-title":"Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy","volume":"132","author":"Cinbo","year":"2013","journal-title":"International journal of cancer"},{"key":"49","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1158\/0008-5472.CAN-11-1919","article-title":"Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts","volume":"72","author":"Giavazzi","year":"2012","journal-title":"Cancer research"},{"key":"50","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/nar\/gkg585","article-title":"MATCH: A tool for searching transcription factor binding sites in DNA sequences","volume":"31","author":"Wingender","year":"2003","journal-title":"Nucleic acids research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T17:08:54Z","timestamp":1718384934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":50,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,5]]}},"alternative-id":["7761","26934321"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7761","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}